{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:14:32Z","timestamp":1789024472625,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejmech.2022.114209","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T11:01:30Z","timestamp":1646478090000},"page":"114209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism"],"prefix":"10.1016","volume":"234","author":[{"given":"Xintong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouchun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-7796","authenticated-orcid":false,"given":"Yonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1965-9396","authenticated-orcid":false,"given":"Yinghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114209_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114209_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/vaccines10010034","article-title":"Overexpression of interleukin-33 in recombinant rabies virus enhances innate and humoral immune responses through activation of dendritic cell-germinal center reactions","volume":"10","author":"Mi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ejmech.2022.114209_bib3","first-page":"1","article-title":"WHO\/Department of control of neglected tropical diseases, WHO expert consultation on rabies. Third report, World Health Organ","year":"2018","journal-title":"Tech. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2022.114209_bib4","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.vaccine.2019.01.065","article-title":"A\u00a0social justice perspective on access to human rabies vaccines","volume":"37","author":"Wentworth","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2022.114209_bib5","doi-asserted-by":"crossref","first-page":"197883","DOI":"10.1016\/j.virusres.2020.197883","article-title":"Seroconversion after three doses of intramuscular rabies vaccine as a post-exposure treatment","volume":"278","author":"Gholami","year":"2020","journal-title":"Virus Res."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2022.114209_bib6","doi-asserted-by":"crossref","first-page":"A54","DOI":"10.1016\/j.vaccine.2019.01.030","article-title":"Rabies post-exposure prophylaxis initiation and adherence among patients in Vietnam, 2014-2016","volume":"37","author":"Tran","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2022.114209_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11908-009-0044-0","article-title":"Update on rabies diagnosis and treatment","volume":"11","author":"Jackson","year":"2019","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.ejmech.2022.114209_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4065\/79.5.671","article-title":"Overview, prevention, and treatment of rabies","volume":"79","author":"Daniel","year":"2004","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejmech.2022.114209_bib9","doi-asserted-by":"crossref","first-page":"598241","DOI":"10.3389\/fphar.2021.598241","article-title":"Clofazimine: a promising inhibitor of rabies virus","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114209_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-021-03431-4","article-title":"Clofazimine broadly inhibits coronaviruses including SARS-CoV-2","volume":"593","author":"Yuan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114209_bib11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jid.2017.09.031","article-title":"The physicochemical basis of clofazimine-induced skin pigmentation","volume":"138","author":"Murashov","year":"2018","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ejmech.2022.114209_bib12","doi-asserted-by":"crossref","first-page":"113562","DOI":"10.1016\/j.ejmech.2021.113562","article-title":"Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in\u00a0vitro and in\u00a0vivo","volume":"222","author":"Koval","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114209_bib13","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1021\/jm300828h","article-title":"Identification of less lipophilic riminophenazine derivatives for the treatment of drug-resistant tuberculosis","volume":"55","author":"Zhang","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114209_bib14","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/cmdc.201900522","article-title":"Novel hydrophilic riminophenazines as potent antiprotozoal agents","volume":"14","author":"Bassanini","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114209_bib15","series-title":"Novel Therapeutic Agents","author":"Rubin","year":"2014"},{"key":"10.1016\/j.ejmech.2022.114209_bib16","article-title":"Use of a riminophenazine for treating MDR resistance","author":"Medlen","year":"1995","journal-title":"Eur. Pat. Appl."},{"key":"10.1016\/j.ejmech.2022.114209_bib17","article-title":"Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity","author":"Liu","year":"2012","journal-title":"PCT Int. Appl."},{"key":"10.1016\/j.ejmech.2022.114209_bib18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/23.5.691","article-title":"Investigation of the structural properties of dihydrophenazines which contribute to their pro-oxidative interactions with human phagocytes","volume":"23","author":"Savage","year":"1989","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114209_bib19","series-title":"Application of Imino Phenazines as Rabies Virus Inhibitors","author":"Wang","year":"2018"},{"key":"10.1016\/j.ejmech.2022.114209_bib20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejmech.2022.114209_bib21","doi-asserted-by":"crossref","first-page":"105196","DOI":"10.1016\/j.bioorg.2021.105196","article-title":"Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage","volume":"115","author":"Wang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114209_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.52547\/ibj.25.4.226","article-title":"Rabies infection: an overview of lyssavirus-host protein interactions","volume":"25","author":"Zandi","year":"2021","journal-title":"Iran. Biomed. J."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:37:17Z","timestamp":1759329437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":22,"alternative-id":["S0223523422001118"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114209","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114209"}}